Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan

ConclusionPatients initiating SGLT2i therapy differed in several characteristics from new users of other OADs. SGLT2i were prescribed more frequently to younger patients, those at increased cardiovascular risk or those with poorer glycemic control.FundingAstellas Pharma Inc., Tokyo, Japan.

Source: Diabetes Therapy - February 7, 2019 Category: Endocrinology Source Type: research